Nodexus Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Employees
  • 13

Employees
  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $30M

  • Investors
  • 17

Nodexus General Information

Description

Developer of a biotechnology platform intended to offer an integrated benchtop system for single-cell analysis, sorting, and dispensing. The company's platform offers affordable automated cell isolation for applications in industry, clinical research, and academia including cell line and antibody development, CRISPR engineering, single-cell genomics and synthetic biology, enabling clients to accelerate biological workflows and make them more widely accessible.

Contact Information

Website
www.nodexus.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 22693 Hesperian Boulevard
  • Suite 175
  • Hayward, CA 94541
  • United States
+1 (510) 000-0000

Nodexus Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nodexus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series A) 16-Dec-2021 $30M 000.00 0000 Completed Generating Revenue
7. Accelerator/Incubator 01-Oct-2020 00.00 Completed Generating Revenue
6. Grant 01-Sep-2020 00.000 00.00 Completed Generating Revenue
5. Grant 20-Sep-2019 00000 00.00 Completed Generating Revenue
4. Accelerator/Incubator 01-Sep-2017 00.00 Completed Generating Revenue
3. Angel (individual) 01-Jan-2015 00.00 Completed Stealth
2. Accelerator/Incubator 02-Dec-2014 Completed Stealth
1. Accelerator/Incubator Completed Stealth
To view Nodexus’s complete valuation and funding history, request access »

Nodexus Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A-1 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A 29,380,646 $0.000100 $1.04 $1.04 1x $1.04 54.07%
To view Nodexus’s complete cap table history, request access »

Nodexus Patents

Nodexus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3579973-A4 Microfluidic system with combined electrical and optical detection for high accuracy particle sorting and methods thereof Pending 07-Feb-2017 00000000000
US-20220291112-A1 Microfluidic system with combined electrical and optical detection for high accuracy particle sorting and methods thereof Pending 07-Feb-2017 00000000000 0
EP-3579973-A1 Microfluidic system with combined electrical and optical detection for high accuracy particle sorting and methods thereof Pending 07-Feb-2017 00000000000
US-20200096436-A1 Microfluidic system with combined electrical and optical detection for high accuracy particle sorting and methods thereof Pending 07-Feb-2017 00000000000
US-20220291111-A1 Microfluidic system with combined electrical and optical detection for high accuracy particle sorting and methods thereof Pending 07-Feb-2017 G01N15/1484 0
To view Nodexus’s complete patent history, request access »

Nodexus Executive Team (4)

Name Title Board Seat Contact Info
Karthik Balakrishnan Ph.D Co-Founder, Chief Executive Officer & Board Member
Anand Kesavaraju Co-Founder, Chief Strategy Officer & Board Member
Hany Nassef Ph.D Vice President, Engineering
You’re viewing 3 of 4 executive team members. Get the full list »

Nodexus Board Members (6)

Name Representing Role Since
Anand Kesavaraju Nodexus Co-Founder, Chief Strategy Officer & Board Member 000 0000
Jonathan Lundt Ph.D RA Capital Management Board Member 000 0000
Karthik Balakrishnan Ph.D Nodexus Co-Founder, Chief Executive Officer & Board Member 000 0000
Michael Pellini MD Section 32 Board Member 000 0000
Theresa Cameron RA Capital Management Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Nodexus Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nodexus Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Grey Sky Venture Partners Venture Capital Minority 000 0000 000000 0
Linden3 Ventures Venture Capital Minority 000 0000 000000 0
RA Capital Management Hedge Fund Minority 000 0000 000000 0
Samudra Pacific Capital Partners Venture Capital Minority 000 0000 000000 0
Section 32 Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 17 investors. Get the full list »